申请人:A. H. Robins Company, Incorporated
公开号:US04556667A1
公开(公告)日:1985-12-03
Novel [2-[(aminopyridinyl)amino]phenyl]arylmethanones and their thioxomethyl, ketal or thioketal analogs of the formula: ##STR1## wherein; R is selected from the group consisting of hydrogen, loweralkyl, --alk.sup.1 --halo, --alk.sup.1 --NR.sup.1 --NR.sup.1 R.sup.2 or --alk.sup.1 --N.dbd.CH--OC.sub.2 H.sub.5 ; R.sup.1 and R.sup.2 are selected from the group consisting of hydrogen, loweralkyl, --C(O)O-loweralkyl or R.sup.1 and R.sup.2 taken together with the adjacent nitrogen atom may form a heterocyclic residue selected from the group consisting of 1-piperidinyl, 1-phthalimido, 1-pyrrolidinyl, 4-morpholinyl, 1-piperazinyl and 4-substituted-1-piperazinyl; B is selected from carbonyl, thioxomethyl, ketal or thioketal; Ar is selected from the group consisting of 2, 3 and 4-pyridinyl, 2 or 3-thienyl, phenyl or phenyl substituted by 1 to 3 radicals selected from halo, loweralkyl, loweralkoxy, trifluoromethyl or nitro and may be the same of different; alk.sup.1 is a straight or branched hydrocarbon chain containing 1-8 carbon atoms; Z is selected from the group consisting of hydrogen, halogen, loweralkyl, loweralkoxy, hydroxy or nitro; Y is selected from the group consisting of hydrogen or 1-2 radicals selected from loweralkyl, loweralkoxy or hydroxy and may be the same of different, and the acid addition salts thereof. These compounds are intermediates in the preparation of novel aryl substituted pyrido[1,4]benzodiazepines having antidepression activity. Some of these intermediates are useful in treating depression.
小说[2-[(氨基吡啶基)氨基]苯基]芳基甲酮及其硫代甲基,缩酮或硫代缩酮类似物的公式:##STR1##其中;R选自氢,较低烷基,--alk.sup.1 --卤,--alk.sup.1 --NR.sup.1 --NR.sup.1 R.sup.2或--alk.sup.1 --N.dbd.CH--OC.sub.2 H.sub.5的群;R.sup.1和R.sup.2选自羟基,较低烷基,--C(O)O-较低烷基或R.sup.1和R.sup.2与相邻的氮原子一起可以形成从1-哌啶基,1-邻苯二甲酰亚胺基,1-吡咯基,4-吗啉基,1-哌嗪基和4-取代-1-哌嗪基中选择的杂环残基的杂环残基;B选自羰基,硫代甲基,缩酮或硫代缩酮;Ar选自2,3和4-吡啶基,2或3-噻吩基,苯基或1至3个基团中选择的卤,较低烷基,较低烷氧基,三氟甲基或硝基的苯基取代物,可以相同也可以不同;alk.sup.1是含有1-8个碳原子的直链或支链烃链;Z选自氢,卤素,较低烷基,较低烷氧基,羟基或硝基;Y选自氢或1-2个从较低烷基,较低烷氧基或羟基中选择的基团,可以相同也可以不同,以及它们的酸加成盐。这些化合物是制备具有抗抑郁活性的新型芳基取代的吡啶[1,4]苯二氮平的中间体。其中一些中间体对治疗抑郁症有用。